Sensorium Therapeutics
Maurizio Fava is a distinguished psychiatrist with extensive experience at Massachusetts General Hospital since July 1990, where roles include Vice Chair of the Executive Committee of Research, Psychiatrist-in-Chief, Executive Director of the Clinical Trials Network and Institute, Director of the Division of Clinical Research, Executive Vice Chair of the Department of Psychiatry, and Director of both the Clinical Research Program and the Depression Clinical and Research Program. Fava's medical education began at the Università degli Studi di Padova, earning a medical degree from 1975 to 1982, and included additional training at the University of Lille 1 Sciences and Technology in 1976. Prior experience includes a psychiatry residency at Massachusetts General Hospital from 1985 to 1988.
This person is not in the org chart
This person is not in any offices
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.